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a b s t r a c t
A screen of microRNA (miRNA) expression following differentiation in human foreskin keratinocytes
(HFKs) identiﬁed changes in several miRNAs, including miR-24 and miR-205. We investigated how
expression of Human Papilloma Virus Type-16 (HPV16) onco-proteins E6 and E7 affected expression of
miR-24 and miR-205 during proliferation and differentiation of HFKs. We show that the induction of both
miR-24 and miR-205 observed during differentiation of HFKs is lost in HFKs expressing E6 and E7. We
demonstrate that the effect on miR-205 is due to E7 activity, as miR-205 expression is dependent on pRb
expression. Finally, we provide evidence that miR-24 effects in the cell may be due to targeting of cyclin
dependent kinase inhibitor p27. In summary, these results indicate that expression of both miR-24 and
miR-205 are impacted by E6 and/or E7 expression, which may be one mechanism by which HPV onco-
proteins can disrupt the balance between proliferation and differentiation in keratinocytes.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
Over the past decade, a growing body of evidence has shown that
microRNAs (miRNAs) play a fundamental role in the development,
function and maintenance of tissues and cells in various organisms.
miRNAs are small, non-coding RNA molecules that can regulate
protein expression at the post-transcriptional level by targeting
mRNAs for degradation or translational repression (Erson and Petty,
2008). It is now known that many miRNAs are implicated in several
disease states, including heart disease (Bauersach and Thum, 2007;
Latronico et al., 2007), viral infection (Sullivan and Ganem, 2005) and
many different cancers (Cowland et al., 2007; Visone and Croce,
2009), leading to increased interest in the biology and function of
individual miRNAs in various cell processes.
In skin physiology, the importance of miRNAs in skin epithelial
development is particularly emphasized when their expression is
repressed by epidermal-speciﬁc deletion of Dicer in mouse models,
which results in several defects, such as epidermal evagination and
abnormal hair follicle development, although it is worth noting that
epidermal differentiation is apparently unaffected (Andl et al., 2006;
Yi et al., 2006). To date, several individual miRNAs have been
identiﬁed as playing fundamental roles in keratinocytes, including
microRNA-205 (miR-205) and microRNA-24 (miR-24).
miR-205 is now known to play a fundamental role in epithelial
biogenesis and maintenance (Qin et al., 2013) and has been widely
studied in a number of settings. It is believed to act as a tumour
suppressor miRNA, since its expression is down-regulated in a
number of different cancers, although more recent evidence has also
shown it may also promote cell proliferation in certain circumstances
(Qin et al., 2013). For example, in both primary human epidermal
keratinocytes and corneal epithelial keratinocytes, it has been shown
to promote migration by regulating the lipid phosphatase SHIP2
(Yu et al., 2008, 2010). In contrast, its tumour suppressor function in
oral keratinocytes has be\en linked to induction of interleukin-24
levels (Kim et al., 2013). Like miR-205, miR-24 also seems to play
contrasting roles depending on the setting, but it is generally found
to be up-regulated in various cancers including oral squamous cell
carcinoma (Lin et al., 2010) and is postulated to have an oncogenic
function. In keratinocytes, it has been implicated in regulation
of differentiation by control of actin adhesion and various cytock-
eletal modulators affecting migration (Amelio et al., 2012), as well
as contributing to FGF-β-mediated regulation of epithelial-to-
mesenchymal tranisiton (EMT) through its targeting of Net1A
(Papadimitriou et al., 2012). Taken together, these keratinocyte
studies demonstrate that both miR-205 and miR-24 play important
roles in keratinocyte proliferation and differentiation, with abnormal
expression of either likely to result in altered cell behaviour.
This becomes important in considering the effect of HPV-16
infection of epithelial cells, since the effect of the viral onco-
proteins E6 and E7 activity is known to impact upon miRNA
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expression (Zheng and Wang, 2011) and could contribute to the
initiation of the tumourigenic process. We have previously reported
that miR-203 expression in human foreskin keratinocytes (HFKs) is
mediated by E6 activity through degradation of p53 (McKenna et al.,
2010), and we concluded that it was likely that other miRNAs were
similarly affected. Therefore, in this report, we investigate how the
expression of miR-24 and miR-205 is affected by expression of HPV
onco-proteins in HFKs during proliferation and differentiation.
Results and discussion
From an initial miRNA screen, carried out in collaboration with
Eric Miska (University of Cambridge), we had noted the expression
levels of several miRNAs in HFKs (Supplementary Table 1). Two
highly expressed miRNAs were miR-205 and miR-24, both of
which showed an increase in expression following differentiation,
suggesting they were important in this process. We validated
these screening results by measuring miR-24 and miR-205 expres-
sion in keratinocytes induced to differentiate by calcium treat-
ment, and in organotypic rafts, which are 3-dimensional skin
equivalents (McCance et al., 1988), derived from normal HFKs.
Quantitative real-time polymerase chain reaction (RQ-PCR)
(Fig. 1a) and Northern blotting (Fig. 1b and c) both show that
miR-24 and miR-205 are signiﬁcantly up-regulated during
calcium-induced HFK differentiation. Likewise, increases in miR-
24 and miR-204 were observed in the organotypic raft model of
keratinocyte differentiation (Fig. 1d–f). Only two other studies have
investigated these miRNAs in differentiation of keratinocytes and our
results agree with their observations that miR-205 is up-regulated
during differentiation of keratinocytes (Nissan et al., 2011), whilst
miR-24 is up-regulated in murine keratinocytes during differentiation
(Amelio et al., 2012). Indeed, both miRNAs have been associated with
differentiation in different settings, suggesting they have a funda-
mental role in mediating the switch from proliferation to differentia-
tion in different cell types.
With this in mind, we wanted to examine the effect of E6 and
E7 onco-proteins on these miRNAs, since studies by ourselves
(McKenna et al., 2010) and others (reviewed in Zheng and Wang,
2011) have shown that cellular miRNA expression can be affected
by HPV infection. We observed by RQ-PCR and Northern blotting
that HFKs transduced to express both E6 and E7 onco-proteins
resulted in increased miR-24 expression (Fig. 2a and c) and
decreased miR-205 expression (Fig. 2b and d). Furthermore, we
noted that the induction of both of these miRNAs during calcium-
induced differentiation was lost in HFKs expressing E6 and E7
(Fig. 2e and f). This is a similar ﬁnding to that which we had
previously observed for miR-203 (McKenna et al., 2010) and is
further evidence that HPV infection of cells can disrupt miRNA
expression.
Since miR-24 and miR-205 have putative roles as an oncogene
and a tumour suppressor respectively, we wanted to speciﬁcally
examine the effect of altering miR-24 and miR-205 expression on
proliferation in cycling HFKs. Levels of both miRNAs were
knocked-down separately in HFKs with speciﬁcally targeted
antagomiR molecules (Fig. 2g). Knockdown of miR-205 resulted
in signiﬁcantly increased HFK proliferation, with 40% more cells
staining for BrdU incorporation than control cells, whilst knocking
Fig. 1. miR-24 and miR-205 are induced during keratinocyte differentiation. (a) RQ-PCR analysis of RNA samples harvested from HFKs following calcium-induced
differentiation demonstrates that miR-24 and miR-205 expression increases signiﬁcantly over time. These results were conﬁrmed by Northern blotting analysis for miR-24
(b) and miR-205 (c). (d) RQ-PCR analysis of RNA samples harvested from organotypic rafts at different time points also demonstrate that miR-24 and miR-205 expression
increases signiﬁcantly over time. These results were conﬁrmed by Northern blotting analysis for miR-24 (e) and miR-205 (f). For ﬁgures (a–c), all images and blots are
representative of 3 independent experiments performed on separate batches of HFKs. Figures (d–f) are representative of two independent experiments performed on
separate batches of HFKs. Data shown in graphs are mean7SE (Student t-test p-values: *po0.05, **po0.01, and ***po0.001).
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down of miR-24 signiﬁcantly inhibited HFK proliferation by 21%
(Fig. 2h). As expected, when miR-24 was over-expressed in HFKs,
we noted that HFK proliferation was signiﬁcantly increased (data
not shown). The proliferative effect of knocking down miR-205
was further illustrated by western blots showing increased activity
of Akt pathway and increased Cyclin D1 levels (Fig. 2i). In the case
of miR-24, we noted that knocking down expression resulted in an
increase of p21 and p27, indicating an inhibition of the cell cycle
(Fig. 2i). These results suggest that, in HFKs, miR-24 and miR-205
nominally behave in an oncogenic and tumour suppressor func-
tion respectively, observations which agree with the roles pro-
posed for them by other studies in keratinocytes (Lin et al., 2010;
Kim et al., 2013). With that in mind, we proceeded to look at each
separately to investigate how these functions might be inﬂuenced
in HFKs.
In our previous study of miR-203 expression in HFKs, we had
demonstrated that miR-205 levels were not signiﬁcantly altered by
knockdown of p53 levels (McKenna et al., 2010). Since miR-205
levels were reduced in HFKs expressing E6 and E7 (Fig. 2a), we
wished to examine if miR-205 expression was dependent upon
pRb expression. Firstly, we examined if E7 expression, rather than
E6, was responsible for determining miR-205 levels. Fig. 3a shows
by RQ-PCR and northern blot that when E7 is expressed alone
(E6sE7 – E6 with stop codon at 5′ end of E6) or with E6 (E6E7),
miR-205 levels are signiﬁcantly reduced. In contrast, when E6
alone is expressed (E6E7s – stop codon at 5′ end of E7), miR-205
levels are not altered, a ﬁnding that is in agreement with our
previous observation that p53 levels do not affect miR-205. Next,
we transiently knocked down pRb levels in HFKs and demon-
strated that miR-205 levels were subsequently decreased as a
result (Fig. 3b). To further validate this ﬁnding, we stably knocked
down pRb in HFKs, using two separate targeting molecules, and
again observed a similarly signiﬁcant decrease in miR-205 levels
(Fig. 3c). For comparison, we included HFKs with stable knock-
down of p53, in which miR-205 levels were not altered, as we
expected. Finally, we took one of the stable pRb knockdown cell
lines and re-expressed wild-type pRb using an adenovirus con-
struct. This rescued the pRb status of the cells and resulted in a
restoration of the miR-205 expression (Fig. 3d). Together, this set
of experiments provide strong evidence that miR-205 expression
Fig. 2. miR-24 and miR-205 expression correlates with proliferative capacity. (a) RQ-PCR analysis and (c) Northern blotting demonstrated that miR-24 expression was
signiﬁcantly increased in HFKs expressing E6 and E7. By contrast miR-205 was shown to be signiﬁcantly decreased in the same cells by RQ-PCR (b) and Northern blotting (d).
When these cells were induced to differentiate by calcium treatment, RQ-PCR shows that the up-regulation of (e) miR-24 expression and (f) miR-205 expression observed in
control (Ctrl) HFKs is lost in HFKs expressing E6 and E7. (g) To test the effect of each miRNA on HFK proliferation, antagomiR inhibitors were separately used to knockdown
levels of each miRNA, conﬁrmed by RQ-PCR. (h) Proliferation, as measured by BrdU incorporation, is increased in HFKs in which miR-205 is inhibited and decreased in HFKs
in which miR-24 is inhibited. (i) Western blots conﬁrming that miR-24 knockdown results in induction of cell cycle inhibitory molecules, whilst miR-205 knockdown causes
increased expression of cell cycle proliferation proteins. All images and blots are representative of three independent experiments performed on separate batches of HFKs.
Data shown in graphs are mean7SE (Student t-test p-values: *po0.05, **po0.01, and ***po0.001).
D.J. McKenna et al. / Virology 448 (2014) 210–216212
is dependent on pRb levels, and explains how E7 inhibition of pRb
may result in decreased miR-205 levels. The mechanism causing
this remains unclear; however, it would seem reasonable to
speculate that E7 inactivation of pRb releases E2F transcription
factors to induce target genes, which may include miRNAs. This
has been shown to be the case for miR-15b in HPV-related anal
carcinoma cells (Myklebust et al., 2011), but there are no reports of
a similar effect on other miRNAs. However, in the case of miR-205,
we see a reduction in expression, suggesting it is repressed rather
than activated. A possible candidate for this repression is another
miRNA, miR-184, which has been shown to antagonize miR-205 in
corneal epithelial keratinocytes (Yu et al., 2008). Although no
studies have investigated regulation of miR-184 activity, analysis
of the promoter region upstream of miR-184 using rVISTA (Loots
and Ovcharenko, 2004) reveals putative E2F and MYC-MAX bind-
ing sites (Supplementary Fig. 2a), so it is tempting to speculate
that either E2F, or E2F-mediated induction of c-MYC expression,
could result in increased miR-184 levels, which in turns represses
miR-205 expression. In the case of miR-24, it is also feasible that
inactivation of pRb also contributes to its up-regulation, since it is
known to be up-regulated by c-MYC (Li et al., 2013) and has
several putative E2F1 binding sites in the vicinity of the miR-23b–
27b–24 cluster region (Supplementary Fig. 2b). Furthermore, a
study by Mishra et al. (2009) suggested that miR-24 regulation
was independent of p53 activity in cancer cells. However, some of
our data (not shown) suggested that E6 and E7 separately resulted
in increased miR-24 levels, but this data was not conclusive
enough to allow us to draw similar conclusions for a relationship
between miR-24 and p53 in HFKs. Ongoing work in our laboratory
intends to explore this further.
We were also interested in the potential targets of miR-24
within the cell. The observation that p27 levels were increased
when miR-24 was knocked down prompted us to investigate
whether it was a potential target of miR-24. Using three miRNA
target prediction algorithm programs, we found that miR-24 was
consistently predicted to target p27 (Fig. 4a and Supplementary
Fig. 3). To test this relationship in vitro, we again knocked down
miR-24 levels in HFKs and demonstrated by RQ-PCR (Fig. 4b)
Fig. 3. miR-205 is pRb dependent. (a) RQ-PCR and Northern blotting show that miR-205 expression is signiﬁcantly decreased in HFKs expressing functional E7 alone (E6sE7)
or with E6 (E6E7), compared to control (Ctrl) cells. However, in cells expressing E6 alone (E6E7s), no signiﬁcant reduction is apparent. Western blotting for p53 and pRb
demonstrates that both E6 and E7 are functional where expected. (b) RQ-PCR and Northern blotting show that transient knockdown of Rb using targeted siRNA (siRb) results
in signiﬁcant decrease of miR-205 compared to cells transfected with non-targeting scramble control (siScr). Western blotting for pRb conﬁrms the knockdown. (c) RQ-PCR
and Northern blotting show that stable knockdown of Rb using two targeted shRNA molecules (shRb1 and shRb2) results in signiﬁcant decrease of miR-205 compared to
cells expressing non-targeting scramble control (shScr). No signiﬁcant decrease of miR-205 was observed in HFKs with stable knockdown of p53 (shp53). Western blotting
for pRb and p53 conﬁrms the respective knockdowns. (d) RQ-PCR and Northern blotting show that re-expressing Rb in shRb2 cells using an adenoviral construct (Ad-WT-Rb)
results in a signiﬁcant increase of miR-205 compared to shRB2 cells with control adenoviral construct (AdGFP). Western blotting for pRb conﬁrms the re-expression.
Numbers above miR-205 panels in Northern blots represent expression signal of miR-205 signal after normalization to U2snRNA expression. All images and blots are
representative of three independent experiments performed on separate batches of HFKs. Data shown in graphs are mean7SE (Student t-test p-values: *po0.05, **po0.01,
and ***po0.001).
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and western blotting (Fig. 4c) that p27 levels were signi-
ﬁcantly increased as a result. In the reverse experiment, we
over-expressed miR-24 levels in HFKs and demonstrated that
p27 levels were signiﬁcantly reduced (Fig. 4b and c). As a control,
we quantiﬁed levels of p16, a known target of miR-24 (Lal et al.,
2008). The fact that altering miR-24 levels results in a similar
pattern of expression for p27 suggested that it may also be a target
and we proceeded to conﬁrm this with a luciferase reporter assay
(Fig. 4d). The luciferase activity of a reporter construct containing
the wild-type p27 3′UTR region (p27-3′UTR) showed signiﬁcant
reduction when miR-24 was over-expressed in the same cells,
indicating that miR-24 was binding to the target region in the 3′
UTR of p27 mRNA (as shown in Supplementary Fig. 3). However,
when miR-24 was over-expressed with a reporter construct which
had mutated residues in the miR-24 binding site of p27 3′UTR
(p27-MUT), no reduction in luciferase activity was observed. This
is strong evidence that miR-24 does indeed regulate p27 levels in
keratinocytes. Our observations are corroborated by a recent study
by Giglio et al. (2013), published while this manuscript was being
prepared, which also demonstrates that miR-24 targets p27 in
keratinocytes. Since we had conﬁrmed this interaction we were
then interested to see if miR-24 levels inversely correlated with
p27 levels during differentiation, so we quantiﬁed p27 by RQ-PCR
(Fig. 4e) and western blotting (Fig. 4f) in samples from our
organotypic raft model. However, we did not observe an exact
correlation since p27 protein levels increase until Day 6, before
decreasing, where we might have expected the increasing levels of
miR-24 to result in decreased p27 levels from Day 0 to Day 9.
However, we had noted a similar delayed response during differ-
entiation between miR-203 and its target p63 (McKenna et al.,
2010), so we suggest that miR-24 may still contribute to the
control of p27 levels during HFK differentiation, although other
mechanisms are likely to also play a role and presumably override
the regulation of p27 by miR-24 during the early period of
differentiation. Indeed, we are inclined to speculate that miR-24
may play differing functions in cycling and differentiating cells. In
cycling cells, the increased miR-24 levels appear to be associated
with the increased proliferation which is exhibited by cycling cells
expressing E6 and E7 compared to control cells. Association of
miR-24 with proliferation is an observation which is supported by
our ﬁndings in Fig. 2(h) and it also agrees with observations by
others, who have shown that miR-24 promotes cell proliferation in
different settings (Lin et al., 2010, Giglio et al., 2013).
However, as we noted in our introduction, miR-24 can play
contrasting roles depending on the setting and there is evidence
from other studies that miR-24 can also inhibit cell proliferation
Fig. 4. p27 is predicted to be a target of hsa-miR-24. (a) Venn diagram displaying numbers of miRNAs computationally predicted to target p27 (CDKN1B) by TargetScan
(green) (http://www.targetscan.org/), PicTar (red) (http://pictar.mdc-berlin.de/) and miRDB (blue) (http://mirdb.org/). (b) RQ-PCR and (c) western blotting show that the
inhibition of miR-24 expression in HFKs results in increased levels of p27, whilst over-expressing miR-24 in these cells results in signiﬁcantly decreased levels of p27. p16, a
known target of miR-24, is shown for comparison. (d) Luciferase activity reporter conﬁrms miR-24 targeting of p27 in HFKs. A reporter construct containing the wild-type
p27 3′UTR region (p27-3′UTR, black bars) shows signiﬁcant reduction of luciferase activity when co-transfected with precursor miR-24 (pre-miR-24) relative to cells co-
transfected with non-targeting control (pre-neg). In cells transfected with a construct containing mutated residues in the miR-24 binding site of p27 3′UTR (p27-MUT, white
bars), no reduction in luciferase activity is observed. (e) RQ-PCR and (f) western blotting for p27 in RNA and protein samples harvested from organotypic rafts at different
time points shows p27 levels initially rise, before decreasing again over the differentiation time. Data shown in ﬁgures (b–d) is representative of three independent
experiments performed on separate batches of HFKs. Figures (e) and (f) are representative of two independent experiments performed on separate batches of HFKs. Data in
graphs is mean7SE (Student t-test p-values: npo0.05, nnpo0.01, and nnnpo0.001).
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(Amelio et al., 2012, Mishra et al., 2009). This is apparently the case
in the differentiation of normal HFKs, where an increase in miR-24
correlates with decreased proliferation, whilst the lack of miR-24
induction noted in cells expressing E6 and E7 associates with
increased proliferation. It is possible that a switch in miR-24
function therefore occurs during HFK differentiation, whereby
proliferation is inhibited instead of promoted. Presumably, this
might be due to the effect of miR-24 on other targets which would
override the proliferative effect of miR-24 noted in cycling cells.
In this study, we have focused on p27 and p16 as targets of miR-24,
but we fully expect other (known and, as yet, unknown) targets of
miR-24 to be also affected, any of which might also contribute to
control of differentiation. Nor can we exclude the possibility that
other miRNAs play a role, including miR-23b and 27b from the
same cluster as miR-24, and also other miRNAs which target p27.
These possible contributing factors may go some way to explaining
why we ﬁnd p27 levels do not exactly correlate with miR-24 levels
during differentiation.
Conclusions
In summary, we have provided further data supporting the
evidence that that miR-24 and miR-205 play important roles in
keratinocytes. We have also shown that the levels of both miRNAs
can be altered by expression of HPV onco-proteins in HFKs. The
expression of miR-205 is dependent upon pRb levels, which means
it is susceptible to alteration by E7 activity. Meanwhile, miR-24 is
apparently up-regulated by E6 and E7 expression and may
promote cell proliferation by targeting the cell cycle inhibitor
p27. These observations provide new evidence as to how HPV
infection can lead to deregulation of proliferation and differentia-
tion in keratinocytes during the development of cervical cancer.
Materials and methods
Cell culture, infections and transfections
Primary human foreskin keratinocytes (HFKs) were isolated
from neonatal foreskin, cultured in low calcium and transduced
with retrovirus produced in ΦNYX-GP packaging cell-line (ATCC)
as previously described (Incassati et al., 2006). Mutagenesis of E6
or E7 was performed as previously described to generate a stop
codon at the 16th amino acid in E7 gene of HPV-16 (E6E7s) (Guess
and McCance, 2005), a stop codon at the 15th amino acid in E6
gene of HPV-16 (E6sE7) (Guess and McCance, 2005). For stable
knockdown of pRb and p53, pSuper-retro constructs expressing
short hairpin RNAs (shRNA) against no known annotated gene
(shScr), 2 regions of Rb 3′UTR (shRb1 and shRb2) and p53 3′UTR
(shp53) were cloned as described previously (Incassati et al.,
2006). Recombinant adenoviruses were cloned using ViraPower
Adenoviral Gateway Expression Kit (Invitrogen) as previously
described (Pickard et al., 2010). For siRNA transfection, control
and RB1 siRNA molecules were purchased from Ambion (Warring-
ton, UK). Transfection was performed at a ﬁnal concentration of
200 nM using FuGene HD for up to 48 h.
Differentiation of HFK cell lines in organotypic raft cultures was
carried out as previously described for transduced lines (McCance
et al., 1988). For calcium-induced differentiation, conﬂuent mono-
layers of HFKs were induced to differentiate by withdrawal of
growth factors and addition of 1.5 mM CaCl2. Transfection of HFKs
with anti-miR-24, pre-miR-24, anti-miR-205, pre-miR-205 and
negative controls (all Ambion) was performed using FuGene HD
(Roche, Mannheim, Germany) following manufacturer's protocols.
Cells were transfected for 48 h with a ﬁnal concentration of 50 nM.
In order to label DNA synthesizing cells, cells in culture were
pulsed for 20 mins with 10 μm BrdU prior to ﬁxation.
Immunoﬂuorescent analysis
BrdU pulsed cells on coverslips were ﬁxed for 10 mins with 4%
paraformaldehyde, washed 3 with PBS, submitted to antigen
retrieval and stained with anti-BrdU (BD Biosciences, Oxford, UK),
A minimum of 10 ﬁelds of view and 4500 cells were counted for
each slide using a Leica AF6000 inverted ﬂuorescence microscope
and Leica AF imaging software. BrdU graphs represent mean7SE
of three independent experiments, expressed relative to number
of BrdU incorporating cells in control experiments.
Luciferase reporter assay
Luciferase reporter constructs based on the pMirTarget ﬁreﬂy
luciferase plasmid were purchased from OriGene Technologies
(Rockville, MD). One construct contained the wild-type p27 3′UTR
region with the miR-24 binding site intact (p27-3′UTR). A matched
control construct contained 2 mutated bases in the miR-24
binding site (cataCTGAGCCAagtat changed to cataCTGTACCAagtat)
(p27-MUT). HFKs were seeded at a concentration of 100,000 cells/
well in 12 well plates and transfected with 500 ng of either p27-
3′UTR plasmid of p27-MUT, together with either pre-miR-24 or
non-targeting negative control (pre-neg) at a concentration of
50 nM. FuGene HD was used for the transfection and 50 ng Renilla
luciferase vector was included in each well to control for transfec-
tion efﬁciency. After 48 h, cells were lysed in lysis buffer (Promega,
Southampton, UK) and luciferase activity measured using the
Dual-Glos Luciferase Assay Kit (Promega) on a FluoStar Omega
plate reader (BMG LabTech, Aylesbury, UK). Transfections were
carried out in triplicate, measurements within experiments were
performed in duplicate, and ﬁreﬂy luciferase readings were
normalized against renilla luciferase readings before analysis.
Western blot analysis
Protein lysates were electrophoresed and equal loading
assessed by Ponceau Red staining following transfer to nitrocellu-
lose membrane. Primary antibodies used for blotting were anti-
pRb, anti-p16, anti-p21Cip1 (all BD Biosciences), anti-p53(DO-1),
anti-p27 (both Santa Cruz), anti-K1, anti-K10 (both Covance,
Cambridge, UK), Cyclin D1, AKT, pAKT(ser473) (all Cell Signaling,
Hertfordshire, UK) and anti-β-actin (Sigma, Poole, UK) as loading
control. Secondary antibodies were goat anti-mouse- and anti-
rabbit-HRP (Santa Cruz). Luminescence was revealed by incuba-
tion with either (Perkin-Elmer) or (Pierce) and signal detected on
an Alpha Innotech FluorChem™ SP imaging system.
RT-PCR analysis
RNA extraction was carried out with High Pure RNA isolation
kit (Roche) according to manufacturer's instructions. 1 μg RNAwas
treated with RQ1 RNAse free DNAse (Promega) prior to ﬁrst strand
cDNA synthesis using random primers with transcriptor high-
ﬁdelity cDNA synthesis kit (Roche) according to manufacturer's
instructions. For real-time PCR, ampliﬁcation of PCR products was
quantiﬁed using FastStart SYBR Green Master (Roche) according to
manufacturers instruction and ﬂuorescence monitored on a DNA
Engines Peltier Thermal Cycler (Bio-Rad) equipped with a
Chromo4 Real-Time PCR Detection System (Bio-Rad) and melting
curve analysis also performed. The cycles of 95 1C – 15 s,
58 1C – 15 s, 60 1C – 60 s, using primer sets for p27 (Forward
5′–TTTGACTTGCATGAAGAGAAGC-3′; Reverse 5′–AGCTGTCTCT-
GAAAGGGACATT–3′), p16 (forward 5′–GTGGACCTGGCTGAGGAG-3′;
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reverse 5′–CTTTCAATCGGGGATGTCTG-3′) and RPLPO (5′–ATCA-
ACGGGTACAAACGAGTC–3′; reverse 5′–CAGATGGATCAGCCAAGAA-
GG–3′). Expression levels were assessed in triplicate, normalized
to RPLPO levels and graphs represent the combined results of
three independent biological replicates.
microRNA real-time PCR
Real-time quantitative PCR (RQ-PCR) of miRNAs was performed
using the miRCURY LNA™microRNA PCR system (Exiqon, Vedbaek,
Denmark). 10 ng template RNA was used in each ﬁrst strand cDNA
synthesis reaction. PCR was performed over 40 ampliﬁcation
cycles and ﬂuorescence monitored as described above. Analysis
was performed using the Opticon Real-Time PCR Detection System
(Bio-Rad). For all RQ-PCR analysis, normalization was against
U6snRNA and error bars represent7SE from three independent
experiments.
Northern blotting for microRNAs
Total RNA was extracted from cells using Trizol (Invitrogen,
Paisley, UK) and quantiﬁed by spectophotometric analysis. North-
ern blotting was performed by resolving 10 mg total RNA on
denaturing polyacrylamide TBE-Urea 15% gels (Invitrogen), trans-
ferring onto BrightStar-Plus positively charged nylon membrane
(Ambion), followed by UV cross-linking. The membrane was
hybridized overnight at 42 1C with DIG-labelled LNA probe speciﬁc
for miR-24 or miR-205 (0.1 nM) (Exiqon) or DIG-labelled antisense
probe to U2snRNA (GGGTGCACCGTTCCTGGAGGTAC) (100 ng/ml).
Following post-hybridization washing, signal detection was per-
formed using the DIG luminescent Detection Kit (Roche). Signal
was detected on an Alpha Innotech FluorChem™ SP imaging
system.
Statistics
Experiments were carried out at least three times, unless
otherwise indicated. Two-tailed Student's t-test was used to
calculate p-values, with thresholds of nnnpo0.001, nnpo0.01,
and npo0.05.
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